+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Companion Animal Osteoarthritis Market Size, Share & Trends Analysis Report By Product (Biologics, Viscosupplements, Pharmaceuticals), By Animal (Canine, Feline, Equine), By Route Of Administration, By End Use, By Region, And Segment Forecasts, 2025 - 2033

  • PDF Icon

    Report

  • 150 Pages
  • July 2025
  • Region: Global
  • Grand View Research
  • ID: 6154605
Description Jump to:
The global companion animal osteoarthritis market size was estimated at USD 2.29 billion in 2024 and is projected to reach USD 13.27 billion by 2033, growing at a CAGR of 23.5% from 2025 to 2033. Key factors expected to drive the market include the rising prevalence of osteoarthritis, increasing R&D initiative, emerging novel treatments, increasing awareness campaigns, and advancing diagnostic techniques increasing adoption of osteoarthritis (OA) treatment.

The rising prevalence of osteoarthritis (OA) in companion animals-particularly dogs, cats, and horses-is significantly driving the global companion animal osteoarthritis market. In canines alone, estimates suggest that approximately 20% of dogs over one year of age show clinical signs of OA, and this prevalence can escalate to as high as 80% in older dogs, according to both clinical observations and radiographic studies. Similar trends are observed in felines, where OA is often underdiagnosed but increasingly recognized in aging cat populations, with some studies indicating radiographic signs in up to 90% of cats over 12 years old. Equine OA also remains a leading cause of reduced performance and early retirement, especially in sport and racehorses.

Several factors are contributing to this increase in OA prevalence, including extended pet lifespans due to advances in nutrition and veterinary care, rising rates of obesity (a major OA risk factor), and improved awareness and diagnostic capabilities among veterinarians and pet owners. These trends are expanding the demand for early diagnosis, chronic disease management, and pain relief solutions.

This growing burden has catalyzed significant investment and innovation in OA therapeutics, including the development of novel biologics, regenerative therapies (e.g., stem cells and PRP), monoclonal antibodies (such as Zoetis’ Librela and Solensia), and other multimodal pain management approaches. Pharmaceutical and biotech companies are actively developing long-acting, targeted therapies that offer better compliance and improved quality of life for pets, particularly as pet owners increasingly seek premium and preventative care. In parallel, the surge in veterinary visits and emphasis on mobility monitoring and wellness programs is reinforcing a robust market for diagnostics, supplements, joint-support diets, and rehabilitation services.

Altogether, these epidemiological and behavioral factors are not only expanding the companion animal OA patient pool but are also transforming the disease into a cornerstone segment of the global animal health industry-creating long-term growth opportunities across therapeutics, diagnostics, and supportive care solutions.

Despite strong market performance and widespread adoption of OA-targeting monoclonal antibodies like Librela, the recent public controversy-including calls for outright bans and new data suggesting a nine fold increase in musculoskeletal adverse events-poses a reputational and regulatory challenge. Heightened scrutiny from regulators like the FDA and EMA may result in tougher post market surveillance, label revisions, or prescribing restrictions. In the short term, veterinarians and pet owners might pivot toward more conservative options, such as established NSAIDs or supplements, potentially slowing growth in the biologics segment. However, transparent safety studies, improved pharmacovigilance, and clear risk-benefit guidelines could restore confidence and ultimately solidify the position of mAb therapies as a premium OA treatment-assuming manufacturers respond proactively

Global Companion Animal Osteoarthritis Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the companion animal osteoarthritis market report based on product, animal, route of administration, end use, and region:

Product Outlook (Revenue, USD Million, 2021 - 2033)

  • Biologics
  • Stem Cells
  • Platelet-Rich Plasma (PRP)
  • Monoclonal Antibodies (mAb)
  • Other Biologics
  • Viscosupplements
  • Pharmaceuticals
  • Steroids
  • NSAIDS
  • Others
  • Nutritional Supplements

Animal Outlook (Revenue, USD Million, 2021 - 2033)

  • Canine
  • Equine
  • Feline

Route of Administration Outlook (Revenue, USD Million, 2021 - 2033)

  • Oral
  • Injectable
  • Intra-muscular
  • Intra-articular
  • Other Injectable
  • Others

End Use Outlook (Revenue, USD Million, 2021 - 2033)

  • Veterinary Hospitals/Clinics
  • E-commerce
  • Others

Regional Outlook (Revenue, USD Million, 2021 - 2033)

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Asia Pacific
  • Japan
  • India
  • China
  • South Korea
  • Australia
  • Thailand
  • Latin America
  • Brazil
  • Argentina
  • Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players worldwide.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets

This product will be delivered within 2 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. Internal Database
1.3.3. Secondary Sources
1.3.4. Primary Research
1.4. Information/Data Analysis
1.5. Market Formulation & Visualization
1.6. Data Validation & Publishing
1.7. Model Details
1.7.1. Commodity flow analysis
1.7.2. Global Market: CAGR Calculation
1.8. List of Secondary Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Companion Animal Osteoarthritis Market Variable Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market
3.1.2. Ancillary Market
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Rising Prevalence of Osteoarthitis
3.2.1.2. Increasing R&D Initiatives
3.2.1.3. Emerging Novel Treatments
3.2.1.4. Increasing Awareness Campaigns
3.2.1.5. Advancing Diagnostic Techniques Increasing Adoption of OA Treatment
3.2.2. Market Restraint Analysis
3.2.2.1. Regulatory Hurdles
3.2.2.2. Emerging Adverse Drug Reactions (ADR)
3.2.2.3. Stringent Regulations
3.2.3. Market Opportunity Analysis
3.2.4. Market Challenge Analysis
3.3. Companion Animal Osteoarthritis Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitution
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political & Legal landscape
3.3.2.2. Economic and Social landscape
3.3.2.3. Technological landscape
3.3.2.4. Environmental landscape
3.3.3. Regulatory Framework by Key Countries
3.3.4. Estimated Animal Population, by Key Species, by Key Countries, 2021-2024
3.3.5. Pipeline/ Clinical Trials Analysis
3.3.6. COVID-19 Impact Analysis
Chapter 4. Companion Animal Osteoarthritis Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Companion Animal Osteoarthritis Market: Product Movement Analysis
4.3. Companion Animal Osteoarthritis Market Size & Trend Analysis, by product, 2021 to 2033 (USD Million)
4.4. Biologics
4.4.1. Biologics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.2. Stem Cells
4.4.2.1. Stem Cells Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.3. Platelet-Rich Plasma (PRP)
4.4.3.1. Platelet-Rich Plasma (PRP) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.4. Monoclonal Antibodies (mAb)
4.4.4.1. Monoclonal Antibodies (mAb) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.5. Other Biologics
4.4.5.1. Other Biologics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5. Viscosupplements
4.5.1. Viscosupplements Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6. Pharmaceuticals
4.6.1. Pharmaceuticals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6.2. Steroids
4.6.2.1. Steroids Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6.3. NSAIDs
4.6.3.1. NSAIDs Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6.4. Others
4.6.4.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.7. Nutritional Supplements
4.7.1. Nutritional Supplements Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. Companion Animal Osteoarthritis Market: Animal Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Companion Animal Osteoarthritis Market: Animal Movement Analysis
5.3. Companion Animal Osteoarthritis Market Size & Trend Analysis, by animal, 2021 to 2033 (USD Million)
5.4. Canine
5.4.1. Canine Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5. Feline
5.5.1. Feline Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.6. Equine
5.6.1. Equine Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 6. Companion Animal Osteoarthritis Market: By Route of Administration Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Companion Animal Osteoarthritis Market: By Route of Administration Movement Analysis
6.3. Companion Animal Osteoarthritis Market Size & Trend Analysis, by route of administration, 2021 to 2033 (USD Million)
6.3.1. Oral
6.3.1.1. Oral Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.3.2. Injectables
6.3.2.1. Injectables Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.3.3. Intra-muscular
6.3.3.1. Intra-muscular Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.3.4. Intra-articular
6.3.4.1. Intra-articular Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.3.5. Other Injectables
6.3.5.1. Other Injectables Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.3.6. Others
6.3.6.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. Companion Animal Osteoarthritis Market: By End Use Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Companion Animal Osteoarthritis Market: By End Use Movement Analysis
7.3. Companion Animal Osteoarthritis Market Size & Trend Analysis, by end use, 2021 to 2033 (USD Million)
7.3.1. Veterinary Hospitals/Clinics
7.3.1.1. Veterinary Hospitals/Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.3.2. E-commerce
7.3.2.1. E-commerce Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.3.3. Others
7.3.3.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 8. Companion Animal Osteoarthritis Market: Regional Estimates & Trend Analysis
8.1. Regional Dashboard
8.2. Companion Animal Osteoarthritis Market Share, By Region, 2024 & 2033 (USD Million)
8.3. Regional Outlook
8.4. North America
8.4.1. North America Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
8.4.2. U.S.
8.4.2.1. Key Country Dynamics
8.4.2.2. U.S. Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
8.4.3. Canada
8.4.3.1. Key Country Dynamics
8.4.3.2. Canada Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
8.4.4. Mexico
8.4.4.1. Key Country Dynamics
8.4.4.2. Mexico Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
8.5. Europe
8.5.1. Europe Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
8.5.2. UK
8.5.2.1. Key Country Dynamics
8.5.2.2. UK Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
8.5.3. Germany
8.5.3.1. Key Country Dynamics
8.5.3.2. Germany Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
8.5.4. France
8.5.4.1. Key Country Dynamics
8.5.4.2. France Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
8.5.5. Italy
8.5.5.1. Key Country Dynamics
8.5.5.2. Italy Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
8.5.6. Spain
8.5.6.1. Key Country Dynamics
8.5.6.2. Spain Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
8.5.7. Denmark
8.5.7.1. Key Country Dynamics
8.5.7.2. Denmark Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
8.5.8. Sweden
8.5.8.1. Key Country Dynamics
8.5.8.2. Sweden Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
8.5.9. Norway
8.5.9.1. Key Country Dynamics
8.5.9.2. Norway Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
8.6. Asia Pacific
8.6.1. Asia Pacific Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
8.6.2. Japan
8.6.2.1. Key Country Dynamics
8.6.2.2. Japan Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
8.6.3. China
8.6.3.1. Key Country Dynamics
8.6.3.2. China Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
8.6.4. India
8.6.4.1. Key Country Dynamics
8.6.4.2. India Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
8.6.5. Australia
8.6.5.1. Key Country Dynamics
8.6.5.2. Australia Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
8.6.6. South Korea
8.6.6.1. Key Country Dynamics
8.6.6.2. South Korea Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
8.6.7. Thailand
8.6.7.1. Key Country Dynamics
8.6.7.2. Thailand Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
8.7. Latin America
8.7.1. Latin America Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
8.7.2. Brazil
8.7.2.1. Key Country Dynamics
8.7.2.2. Brazil Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033
8.7.3. Argentina
8.7.3.1. Key Country Dynamics
8.7.3.2. Argentina Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
8.8. Middle East & Africa
8.8.1. Middle East & Africa Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
8.8.2. South Africa
8.8.2.1. Key Country Dynamics
8.8.2.2. South Africa Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
8.8.3. Saudi Arabia
8.8.3.1. Key Country Dynamics
8.8.3.2. Saudi Arabia Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
8.8.4. UAE
8.8.4.1. Key Country Dynamics
8.8.4.2. UAE Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
8.8.5. Kuwait
8.8.5.1. Key Country Dynamics
8.8.5.2. Kuwait Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
Chapter 9. Competitive Landscape
9.1. Market Participant Categorization
9.2. Company Market Position Analysis/ Heap Map Analysis
9.3. Company Profiles
9.3.1. Zoetis
9.3.1.1. Participant’s Overview
9.3.1.2. Financial Performance
9.3.1.3. Product Benchmarking
9.3.1.4. Strategic Initiatives
9.3.2. Boehringer Ingelheim
9.3.2.1. Participant’s Overview
9.3.2.2. Financial Performance
9.3.2.3. Product Benchmarking
9.3.2.4. Strategic Initiatives
9.3.3. Elanco Animal Health
9.3.3.1. Participant’s Overview
9.3.3.2. Financial Performance
9.3.3.3. Product Benchmarking
9.3.3.4. Strategic Initiatives
9.3.4. American Regent, Inc.
9.3.4.1. Participant’s Overview
9.3.4.2. Financial Performance
9.3.4.3. Product Benchmarking
9.3.4.4. Strategic Initiatives
9.3.5. Merck Animal Health (Merck & Co. Inc)
9.3.5.1. Participant’s Overview
9.3.5.2. Financial Performance
9.3.5.3. Product Benchmarking
9.3.5.4. Strategic Initiatives
9.3.6. Vetoquinol S.A.
9.3.6.1. Participant’s Overview
9.3.6.2. Financial Performance
9.3.6.3. Product Benchmarking
9.3.6.4. Strategic Initiatives
9.3.7. Ceva Sante Animale
9.3.7.1. Participant’s Overview
9.3.7.2. Financial Performance
9.3.7.3. Product Benchmarking
9.3.7.4. Strategic Initiatives
9.3.8. Virbac
9.3.8.1. Participant’s Overview
9.3.8.2. Financial Performance
9.3.8.3. Product Benchmarking
9.3.8.4. Strategic Initiatives
9.3.9. Biogenesis Bago
9.3.9.1. Participant’s Overview
9.3.9.2. Financial Performance
9.3.9.3. Product Benchmarking
9.3.9.4. Strategic Initiatives
9.3.10. Ardent Animal Health, Llc
9.3.10.1. Participant’s Overview
9.3.10.2. Financial Performance
9.3.10.3. Product Benchmarking
9.3.10.4. Strategic Initiatives
9.3.11. PetVivo Holdings, Inc. (Spryng)
9.3.11.1. Participant’s Overview
9.3.11.2. Financial Performance
9.3.11.3. Product Benchmarking
9.3.11.4. Strategic Initiatives
9.3.12. VetStem Inc.
9.3.12.1. Participant’s Overview
9.3.12.2. Financial Performance
9.3.12.3. Product Benchmarking
9.3.12.4. Strategic Initiatives
9.3.13. Enso Discoveries
9.3.13.1. Participant’s Overview
9.3.13.2. Financial Performance
9.3.13.3. Product Benchmarking
9.3.13.4. Strategic Initiatives
9.3.14. Contura Vet US
9.3.14.1. Participant’s Overview
9.3.14.2. Financial Performance
9.3.14.3. Product Benchmarking
9.3.14.4. Strategic Initiatives
9.3.15. T-Cyte Therapeutics
9.3.15.1. Participant’s Overview
9.3.15.2. Financial Performance
9.3.15.3. Product Benchmarking
9.3.15.4. Strategic Initiatives
9.3.16. Medrego Llc.
9.3.16.1. Participant’s Overview
9.3.16.2. Financial Performance
9.3.16.3. Product Benchmarking
9.3.16.4. Strategic Initiatives
9.4. Strategy Mapping
9.4.. Mergers & Acquisitions
9.4.2. Partnerships & Collaborations
9.4.3. Expansion
9.4.4. Product launch
9.4.5. Product Approval
9.4.6. Others
9.5. List of Key Companies
9.5.1. List of Manufacturers
9.5.2. List of Distributors
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
Table 4 Global Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
Table 5 Global Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
Table 6 Global Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
Table 7 Global Companion Animal Osteoarthritis Market, by Region, 2021 - 2033 (USD Million)
Table 8 North America Companion Animal Osteoarthritis Market, by Country, 2021 - 2033 (USD Million)
Table 9 North America Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
Table 10 North America Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
Table 11 North America Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
Table 12 North America Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
Table 13 U.S. Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
Table 14 U.S. Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
Table 15 U.S. Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
Table 16 U.S. Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
Table 17 Canada Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
Table 18 Canada Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
Table 19 Canada Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
Table 20 Canada Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
Table 21 Mexico Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
Table 22 Mexico Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
Table 23 Mexico Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
Table 24 Mexico Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
Table 25 Europe Companion Animal Osteoarthritis Market, by Country, 2021 - 2033 (USD Million)
Table 26 Europe Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
Table 27 Europe Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
Table 28 Europe Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
Table 29 Europe Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
Table 30 UK Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
Table 31 UK Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
Table 32 UK Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
Table 33 UK Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
Table 34 Germany Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
Table 35 Germany Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
Table 36 Germany Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
Table 37 Germany Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
Table 38 France Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
Table 39 France Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
Table 40 France Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
Table 41 France Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
Table 42 Italy Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
Table 43 Italy Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
Table 44 Italy Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
Table 45 Italy Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
Table 46 Spain Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
Table 47 Spain Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
Table 48 Spain Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
Table 49 Spain Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
Table 50 Denmark Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
Table 51 Denmark Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
Table 52 Denmark Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
Table 53 Denmark Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
Table 54 Sweden Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
Table 55 Sweden Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
Table 56 Sweden Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
Table 57 Sweden Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
Table 58 Norway Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
Table 59 Norway Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
Table 60 Norway Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
Table 61 Norway Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
Table 62 Asia Pacific Companion Animal Osteoarthritis Market, by Country, 2021 - 2033 (USD Million)
Table 63 Asia Pacific Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
Table 64 Asia Pacific Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
Table 65 Asia Pacific Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
Table 66 Asia Pacific Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
Table 67 China Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
Table 68 China Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
Table 69 China Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
Table 70 China Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
Table 71 Japan Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
Table 72 Japan Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
Table 73 Japan Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
Table 74 Japan Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
Table 75 India Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
Table 76 India Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
Table 77 India Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
Table 78 India Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
Table 79 South Korea Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
Table 80 South Korea Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
Table 81 South Korea Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
Table 82 South Korea Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
Table 83 Australia Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
Table 84 Australia Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
Table 85 Australia Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
Table 86 Australia Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
Table 87 Thailand Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
Table 88 Thailand Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
Table 89 Thailand Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
Table 90 Thailand Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
Table 91 Latin America Companion Animal Osteoarthritis Market, by Country, 2021 - 2033 (USD Million)
Table 92 Latin America Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
Table 93 Latin America Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
Table 94 Latin America Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
Table 95 Latin America Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
Table 96 Brazil Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
Table 97 Brazil Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
Table 98 Brazil Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
Table 99 Brazil Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
Table 100 Brazil Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
Table 101 Argentina Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
Table 102 Argentina Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
Table 103 Argentina Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
Table 104 Middle East & Africa Companion Animal Osteoarthritis Market, by Country, 2021 - 2033 (USD Million)
Table 105 Middle East & Africa Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
Table 106 Middle East & Africa Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
Table 107 Middle East & Africa Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
Table 108 Middle East & Africa Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
Table 109 South Africa Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
Table 110 South Africa Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
Table 111 South Africa Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
Table 112 South Africa Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
Table 113 Saudi Arabia Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
Table 114 Saudi Arabia Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
Table 115 Saudi Arabia Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
Table 116 Saudi Arabia Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
Table 117 UAE Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
Table 118 UAE Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
Table 119 UAE Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
Table 120 UAE Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
Table 121 Kuwait Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
Table 122 Kuwait Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
Table 123 Kuwait Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
Table 124 Kuwait Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Information Procurement
Fig. 3 Primary Research Pattern
Fig. 4 Market Research Approaches
Fig. 5 Value Chain-Based Sizing & Forecasting
Fig. 6 Market Formulation & Validation
Fig. 7 Companion Animal Osteoarthritis Market, Market Segmentation
Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 10 Market Challenge Relevance Analysis (Current & Future Impact)
Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 12 Porter’s Five Forces Analysis
Fig. 13 Regional Marketplace: Key Takeaways
Fig. 14 Global Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
Fig. 15 Global Companion Animal Osteoarthritis Market, for Biologics, 2021 - 2033 (USD Million)
Fig. 16 Global Companion Animal Osteoarthritis Market, for Stem Cells, 2021 - 2033 (USD Million)
Fig. 17 Global Companion Animal Osteoarthritis Market, for Platelet-Rich Plasma (PRP), 2021 - 2033 (USD Million)
Fig. 18 Global Companion Animal Osteoarthritis Market, for Monoclonal Antibodies (mAb), 2021 - 2033 (USD Million)
Fig. 19 Global Companion Animal Osteoarthritis Market, for Other Biologics, 2021 - 2033 (USD Million)
Fig. 20 Global Companion Animal Osteoarthritis Market, for Viscosupplements, 2021 - 2033 (USD Million)
Fig. 21 Global Companion Animal Osteoarthritis Market, for Pharmaceuticals, 2021 - 2033 (USD Million)
Fig. 22 Global Companion Animal Osteoarthritis Market, for Steroids, 2021 - 2033 (USD Million)
Fig. 23 Global Companion Animal Osteoarthritis Market, for NSAIDS, 2021 - 2033 (USD Million)
Fig. 24 Global Companion Animal Osteoarthritis Market, for Others, 2021 - 2033 (USD Million)
Fig. 25 Global Companion Animal Osteoarthritis Market, for Nutritional Supplements, 2021 - 2033 (USD Million)
Fig. 26 Global Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
Fig. 27 Global Companion Animal Osteoarthritis Market, for Canine, 2021 - 2033 (USD Million)
Fig. 28 Global Companion Animal Osteoarthritis Market, for Equine, 2021 - 2033 (USD Million)
Fig. 29 Global Companion Animal Osteoarthritis Market, for Feline, 2021 - 2033 (USD Million)
Fig. 30 Global Companion Animal Osteoarthritis Market, for By Route of Administration, 2021 - 2033 (USD Million)
Fig. 31 Global Companion Animal Osteoarthritis Market, for Oral, 2021 - 2033 (USD Million)
Fig. 32 Global Companion Animal Osteoarthritis Market, for Injectable, 2021 - 2033 (USD Million)
Fig. 33 Global Companion Animal Osteoarthritis Market, for Intra-muscular, 2021 - 2033 (USD Million)
Fig. 34 Global Companion Animal Osteoarthritis Market, for Intra-articular, 2021 - 2033 (USD Million)
Fig. 35 Global Companion Animal Osteoarthritis Market, for Other Injectable, 2021 - 2033 (USD Million)
Fig. 36 Global Companion Animal Osteoarthritis Market, for Others, 2021 - 2033 (USD Million)
Fig. 37 Global Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
Fig. 38 Global Companion Animal Osteoarthritis Market, for Veterinary Hospitals/Clinics, 2021 - 2033 (USD Million)
Fig. 39 Global Companion Animal Osteoarthritis Market, for E-commerce, 2021 - 2033 (USD Million)
Fig. 40 Global Companion Animal Osteoarthritis Market, for Others, 2021 - 2033 (USD Million)
Fig. 41 Regional Outlook, 2024 & 2033
Fig. 42 North America Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
Fig. 43 U.S. Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
Fig. 44 Canada Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
Fig. 45 Mexico Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
Fig. 46 Europe Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
Fig. 47 UK Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
Fig. 48 Germany Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
Fig. 49 France Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
Fig. 50 Italy Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
Fig. 51 Spain Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
Fig. 52 Sweden Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
Fig. 53 Denmark Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
Fig. 54 Norway Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
Fig. 55 Asia Pacific Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
Fig. 56 Japan Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
Fig. 57 China Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
Fig. 58 India Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
Fig. 59 Australia Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
Fig. 60 South Korea Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
Fig. 61 Thailand Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
Fig. 62 Latin America Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
Fig. 63 Brazil Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
Fig. 64 Argentina Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
Fig. 65 Middle East and Africa Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
Fig. 66 South Africa Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
Fig. 67 Saudi Arabia Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
Fig. 68 UAE Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
Fig. 69 Kuwait Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)

Companies Mentioned

  • Zoetis Inc.
  • Boehringer Ingelheim
  • Elanco Animal Health
  • American Regent, Inc.
  • Merck Animal Health (Merck & Co. Inc)
  • Vetoquinol S.A.
  • Ceva Sante Animale
  • Virbac
  • Biogenesis Bago
  • Ardent Animal Health, LLC
  • PetVivo Holdings, Inc. (Spryng)
  • VetStem, Inc.
  • Enso Discoveries
  • Contura Vet US
  • T-Cyte Therapeutics
  • MEDREGO LLC

Related Topics

Related Reports

U.S. Companion Animal Osteoarthritis Market Size, Share & Trends Analysis Report By Product (Biologics, Pharmaceuticals, Viscosupplements, Nutritional Supplements), By Animal, By Route of Administration, By End-use, And Segment Forecasts, 2025 - 2033 - Product Image

U.S. Companion Animal Osteoarthritis Market Size, Share & Trends Analysis Report By Product (Biologics, Pharmaceuticals, Viscosupplements, Nutritional Supplements), By Animal, By Route of Administration, By End-use, And Segment Forecasts, 2025 - 2033

  • Report
  • 150 Pages
  • United States
From
Osteoarthritis Therapeutics Market Size, Share & Trends Analysis Report By Drug Type (NSAIDs, Corticosteroids), By Anatomy (Hip Osteoarthritis), By Route Of Administration (Topical Route, Oral Route), By Sales Channel, By End-use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Osteoarthritis Therapeutics Market Size, Share & Trends Analysis Report By Drug Type (NSAIDs, Corticosteroids), By Anatomy (Hip Osteoarthritis), By Route Of Administration (Topical Route, Oral Route), By Sales Channel, By End-use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From
Naproxen Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2035F - Product Image

Naproxen Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2035F

  • Report
  • 183 Pages
  • Global
From
Osteoarthritis Pain Drug Market by Product Type, Route Of Administration, Distribution Channel, End User, Patient Age Group, Disease Severity - Global Forecast 2025-2030 - Product Image

Osteoarthritis Pain Drug Market by Product Type, Route Of Administration, Distribution Channel, End User, Patient Age Group, Disease Severity - Global Forecast 2025-2030

  • Report
  • 197 Pages
  • Global
From
Osteoarthritis Cell Therapy Market by Product Type (Allogeneic, Autologous), Cell Type (Chondrocytes, Mesenchymal Stem Cells), Source, Indication, Application, End User, Route of Administration, Technique - Global Forecast 2025-2030 - Product Image

Osteoarthritis Cell Therapy Market by Product Type (Allogeneic, Autologous), Cell Type (Chondrocytes, Mesenchymal Stem Cells), Source, Indication, Application, End User, Route of Administration, Technique - Global Forecast 2025-2030

  • Report
  • 183 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.